Patient Blood Management Market by Product (Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device), Accessories (Syringes, Vials), Reagents, Software)), Component, End User (Blood Bank, Hospital) - Global Forecast to 2024
“The patient blood management market is projected to reach USD 15.3 billion by 2024.”
The patient blood management market is projected to reach USD 15.3 billion by 2024 from USD 10.7 billion in 2019, at a CAGR of 7.4% from 2019 to 2024. The growth in this market is mainly driven by the rising number of blood donations and blood donors, surge in the prevalence of blood disorders, and rising awareness about blood transfusion safety. However, the high cost of automated instruments is expected to hinder their adoption among end users during the forecast period.
“Blood transfusion segment of instruments to register significant growth due to technological advancements.”
The product segment of the patient blood management market is segmented into instruments, accessories, reagents & kits, and software. The instrument segment is further sub-segmented into blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, and blood storage devices. Technological advancements, new product launches, coupled with the increasing use of autotransfusion systems during critical surgical procedures and organ transplantation, are expected to drive the growth of this segment in the near future.
“On the basis of component, the whole blood segment commanded the leading market share in 2018.”
In terms of components, the patient blood management market is segmented into whole blood and blood components. In 2018, the whole blood segment commanded a major share of the market due to the increasing number of blood donors and blood donations across the globe. Moreover, the increasing prevalence of blood disorders such as anemia and blood cancer that require whole-blood units and RBCs for blood transfusions will further increase the demand for whole blood units, thus contributing to the market growth.
“The US patient blood management market to hold a prominent market share during the forecast period.”
The patient blood management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The US held the major share of the global patient blood management in 2018. Factors such as new product launches and technological advancements in patient blood management products and the presence of key players in this region are driving the growth of this market in the US. Moreover, favorable reimbursement guidelines and high awareness about blood transfusion safety will further fuel market growth.
Breakdown of supply-side primary interviews:
Research Coverage
This report studies the patient blood management market based on product, component, end user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to individual growth trends, and it also forecasts the revenue of the market segments with respect to five mainregions.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; and high-growth countries along with their respective drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
The patient blood management market is projected to reach USD 15.3 billion by 2024 from USD 10.7 billion in 2019, at a CAGR of 7.4% from 2019 to 2024. The growth in this market is mainly driven by the rising number of blood donations and blood donors, surge in the prevalence of blood disorders, and rising awareness about blood transfusion safety. However, the high cost of automated instruments is expected to hinder their adoption among end users during the forecast period.
“Blood transfusion segment of instruments to register significant growth due to technological advancements.”
The product segment of the patient blood management market is segmented into instruments, accessories, reagents & kits, and software. The instrument segment is further sub-segmented into blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, and blood storage devices. Technological advancements, new product launches, coupled with the increasing use of autotransfusion systems during critical surgical procedures and organ transplantation, are expected to drive the growth of this segment in the near future.
“On the basis of component, the whole blood segment commanded the leading market share in 2018.”
In terms of components, the patient blood management market is segmented into whole blood and blood components. In 2018, the whole blood segment commanded a major share of the market due to the increasing number of blood donors and blood donations across the globe. Moreover, the increasing prevalence of blood disorders such as anemia and blood cancer that require whole-blood units and RBCs for blood transfusions will further increase the demand for whole blood units, thus contributing to the market growth.
“The US patient blood management market to hold a prominent market share during the forecast period.”
The patient blood management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The US held the major share of the global patient blood management in 2018. Factors such as new product launches and technological advancements in patient blood management products and the presence of key players in this region are driving the growth of this market in the US. Moreover, favorable reimbursement guidelines and high awareness about blood transfusion safety will further fuel market growth.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1 - 45%, Tier 2 - 34%, and Tier 3 - 21%
- By Designation: C-level - 47%, Director-level - 33%, and Others - 20%
- By Region: North America- 35%, Europe - 32%, APAC - 25%, Latin America- 6%, and MEA - 2%
Research Coverage
This report studies the patient blood management market based on product, component, end user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to individual growth trends, and it also forecasts the revenue of the market segments with respect to five mainregions.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; and high-growth countries along with their respective drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
2.1.2.2 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
2.2.1 PRODUCT-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MARKET ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PATIENT BLOOD MANAGEMENT MARKET OVERVIEW
4.2 PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT
4.3 PATIENT BLOOD MANAGEMENT MARKET, BY END USER
4.4 PATIENT BLOOD MANAGEMENT MARKET: REGIONAL GROWTH FORECASTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing demand for donated blood
5.2.1.2 Increasing number of blood donations and blood donors
5.2.1.3 Rising prevalence of target diseases
5.2.1.4 Regulatory guidelines for safe blood transfusion
5.2.1.5 Technological advancements in the patient blood management industry
5.2.2 RESTRAINTS
5.2.2.1 High cost associated with automated systems
5.2.3 OPPORTUNITIES
5.2.3.1 Market penetration opportunities in developing countries
5.2.3.2 Growing awareness regarding the safety of donated blood
6 PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 INSTRUMENTS
6.2.1 BLOOD PROCESSING DEVICES
6.2.1.1 Blood cell processors
6.2.1.1.1 Technological advancements in centrifugation systems might replace blood cell processors in the near future
6.2.1.2 Centrifuges
6.2.1.2.1 Longer lifespan of centrifuge systems to limit the growth of this segment
6.2.2 BLOOD TRANSFUSION DEVICES
6.2.2.1 Apheresis machines
6.2.2.1.1 Favorable reimbursement for therapeutic apheresis procedures to support market growth
6.2.2.2 Cell salvage systems
6.2.2.2.1 High cost of cell salvage systems as well as the dearth of trained professionals to restrain market growth
6.2.3 BLOOD CULTURE SCREENING DEVICES
6.2.3.1 Automated blood culture systems
6.2.3.1.1 Automated blood culture systems segment to witness higher growth during the forecast period
6.2.3.2 Supporting laboratory equipment
6.2.3.2.1 Growing automation to support the adoption of these equipment among end users
6.2.4 DIAGNOSTIC & TESTING INSTRUMENTS
6.2.4.1 PCR instruments
6.2.4.1.1 Significant adoption of RT-PCR to fuel market growth
6.2.4.2 Hematology analyzers
6.2.4.2.1 Technological advancements to support market growth
6.2.4.3 NGS platforms
6.2.4.3.1 RNA-Seq is an emerging approach for HIV testing
6.2.4.4 Blood grouping analyzers
6.2.4.4.1 Increasing adoption of blood grouping analyzers by blood banks to support market growth
6.2.4.5 Other instruments
6.2.5 BLOOD STORAGE DEVICES
6.2.5.1 Medical refrigerators
6.2.5.1.1 Medical refrigerators accounted for the largest share of the blood storage devices market in 2018
6.2.5.2 Medical freezers
6.2.5.2.1 Technological advancements to fuel market growth
6.3 ACCESSORIES
6.3.1 SYRINGES & NEEDLES
6.3.1.1 Easy availability and low cost of syringes and needles driving their adoption
6.3.2 VIALS & TUBES
6.3.2.1 Easier sample collection driving the adoption of vials and tubes
6.3.3 BLOOD BAGS
6.3.3.1 Increasing number of blood donations to support market growth
6.3.4 OTHER ACCESSORIES
6.4 REAGENTS AND KITS
6.4.1 BLOOD CULTURE MEDIA
6.4.1.1 A wide range of blood culture media are offered by companies
6.4.2 BLOOD TYPING REAGENTS
6.4.2.1 Mandatory use of ABO test prior to blood transfusion—A major factor supporting market growth
6.4.3 SLIDE STAINING REAGENTS
6.4.3.1 Rising applications of staining techniques to support market growth
6.4.4 ASSAY KITS
6.4.4.1 Growing adoption of NAT tests across the globe to support market growth
6.4.5 OTHER REAGENTS
6.5 SOFTWARE
6.5.1 BLOOD BANK AND TRANSFUSION MANAGEMENT SOFTWARE
6.5.1.1 This software segment to register the highest growth rate over the forecast period
6.5.2 OTHER SOFTWARE
7 PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT
7.1 INTRODUCTION
7.2 WHOLE BLOOD
7.2.1 GROWING DISEASE INCIDENCE AND RISING SURGICAL VOLUMES ARE DRIVING THE DEMAND FOR WHOLE BLOOD UNITS
7.3 BLOOD COMPONENTS
7.3.1 EXPANDING APPLICATIONS OF BLOOD PLASMA AND PLATELETS TO SUPPORT MARKET GROWTH
8 PATIENT BLOOD MANAGEMENT MARKET, BY END USER
8.1 INTRODUCTION
8.2 BLOOD BANKS
8.2.1 HIGH DEMAND FOR SAFE BLOOD IS DRIVING THE GROWTH OF THIS END-USER SEGMENT
8.3 HOSPITALS
8.3.1 LARGE VOLUME OF SURGICAL PROCEDURES PERFORMED IN HOSPITALS—MAJOR FACTOR DRIVING THE GROWTH OF THIS END-USER SEGMENT
9 PATIENT BLOOD MANAGEMENT MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 The US dominates the patient blood management market due to the presence of well-developed healthcare infrastructure & growing adoption of advanced technologies
9.2.2 CANADA
9.2.2.1 Increasing number of surgical procedures performed in the country to drive the market for patient blood management products
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Rising number of trauma cases and accidents to support market growth
9.3.2 UK
9.3.2.1 Rising number of road traffic accidents will support the growth of this market
9.3.3 FRANCE
9.3.3.1 Rising prevalence of blood disorders to support market growth in France
9.3.4 ITALY
9.3.4.1 Increasing awareness about safe blood transfusion will drive market growth
9.3.5 SPAIN
9.3.5.1 Government mandates to deliver safe blood for transfusion to support market growth
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.1.1 Well-developed healthcare system and favorable reimbursement policy in the country to support market growth
9.4.2 CHINA
9.4.2.1 Market in China is estimated to grow at a high rate during the forecast period
9.4.3 INDIA
9.4.3.1 Favorable government initiatives to support market growth
9.4.4 AUSTRALIA
9.4.4.1 Presence of a highly developed healthcare system to contribute to market growth
9.4.5 SOUTH KOREA
9.4.5.1 Implementation of favorable government initiatives to support market growth
9.4.6 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 BRAZIL
9.5.1.1 Growing medical tourism to support market growth in Brazil
9.5.2 MEXICO
9.5.2.1 Lack of awareness about blood donations to hamper market growth
9.5.3 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET RANKING ANALYSIS, 2018
10.3 COMPETITIVE SCENARIO
10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2019)
10.3.2 PRODUCT LAUNCHES (2017–2019)
10.3.3 EXPANSIONS (2017–2019)
10.3.4 ACQUISITIONS (2017–2019)
10.4 COMPETITIVE LEADERSHIP MAPPING (2019)
10.4.1 VENDOR INCLUSION CRITERIA
10.4.2 VISIONARY LEADERS
10.4.3 INNOVATORS
10.4.4 DYNAMIC DIFFERENTIATORS
10.4.5 EMERGING COMPANIES
11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 ABBOTT LABORATORIES
11.2 ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF ASAHI KASEI CORPORATION)
11.3 B. BRAUN MELSUNGEN AG
11.4 BIOM?RIEUX SA
11.5 BIO-RAD LABORATORIES, INC.
11.6 DANAHER CORPORATION
11.7 F. HOFFMANN-LA ROCHE LTD.
11.8 FRESENIUS SE & CO. KGAA
11.9 GRIFOLS, S.A.
11.10 HAEMONETICS CORPORATION
11.11 IMMUCOR, INC.
11.12 KANEKA CORPORATION
11.13 LIVANOVA PLC
11.14 MACOPHARMA
11.15 TERUMO CORPORATION
11.16 OTHER COMPANIES
11.16.1 MEDIWARE INFORMATION SYSTEMS
11.16.2 KAWASUMI LABORATORIES, INC.
11.16.3 HAIER BIOMEDICAL
11.16.4 DIATRON
11.16.5 BAG DIAGNOSTICS GMBH
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
2.1.2.2 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
2.2.1 PRODUCT-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MARKET ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PATIENT BLOOD MANAGEMENT MARKET OVERVIEW
4.2 PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT
4.3 PATIENT BLOOD MANAGEMENT MARKET, BY END USER
4.4 PATIENT BLOOD MANAGEMENT MARKET: REGIONAL GROWTH FORECASTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing demand for donated blood
5.2.1.2 Increasing number of blood donations and blood donors
5.2.1.3 Rising prevalence of target diseases
5.2.1.4 Regulatory guidelines for safe blood transfusion
5.2.1.5 Technological advancements in the patient blood management industry
5.2.2 RESTRAINTS
5.2.2.1 High cost associated with automated systems
5.2.3 OPPORTUNITIES
5.2.3.1 Market penetration opportunities in developing countries
5.2.3.2 Growing awareness regarding the safety of donated blood
6 PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 INSTRUMENTS
6.2.1 BLOOD PROCESSING DEVICES
6.2.1.1 Blood cell processors
6.2.1.1.1 Technological advancements in centrifugation systems might replace blood cell processors in the near future
6.2.1.2 Centrifuges
6.2.1.2.1 Longer lifespan of centrifuge systems to limit the growth of this segment
6.2.2 BLOOD TRANSFUSION DEVICES
6.2.2.1 Apheresis machines
6.2.2.1.1 Favorable reimbursement for therapeutic apheresis procedures to support market growth
6.2.2.2 Cell salvage systems
6.2.2.2.1 High cost of cell salvage systems as well as the dearth of trained professionals to restrain market growth
6.2.3 BLOOD CULTURE SCREENING DEVICES
6.2.3.1 Automated blood culture systems
6.2.3.1.1 Automated blood culture systems segment to witness higher growth during the forecast period
6.2.3.2 Supporting laboratory equipment
6.2.3.2.1 Growing automation to support the adoption of these equipment among end users
6.2.4 DIAGNOSTIC & TESTING INSTRUMENTS
6.2.4.1 PCR instruments
6.2.4.1.1 Significant adoption of RT-PCR to fuel market growth
6.2.4.2 Hematology analyzers
6.2.4.2.1 Technological advancements to support market growth
6.2.4.3 NGS platforms
6.2.4.3.1 RNA-Seq is an emerging approach for HIV testing
6.2.4.4 Blood grouping analyzers
6.2.4.4.1 Increasing adoption of blood grouping analyzers by blood banks to support market growth
6.2.4.5 Other instruments
6.2.5 BLOOD STORAGE DEVICES
6.2.5.1 Medical refrigerators
6.2.5.1.1 Medical refrigerators accounted for the largest share of the blood storage devices market in 2018
6.2.5.2 Medical freezers
6.2.5.2.1 Technological advancements to fuel market growth
6.3 ACCESSORIES
6.3.1 SYRINGES & NEEDLES
6.3.1.1 Easy availability and low cost of syringes and needles driving their adoption
6.3.2 VIALS & TUBES
6.3.2.1 Easier sample collection driving the adoption of vials and tubes
6.3.3 BLOOD BAGS
6.3.3.1 Increasing number of blood donations to support market growth
6.3.4 OTHER ACCESSORIES
6.4 REAGENTS AND KITS
6.4.1 BLOOD CULTURE MEDIA
6.4.1.1 A wide range of blood culture media are offered by companies
6.4.2 BLOOD TYPING REAGENTS
6.4.2.1 Mandatory use of ABO test prior to blood transfusion—A major factor supporting market growth
6.4.3 SLIDE STAINING REAGENTS
6.4.3.1 Rising applications of staining techniques to support market growth
6.4.4 ASSAY KITS
6.4.4.1 Growing adoption of NAT tests across the globe to support market growth
6.4.5 OTHER REAGENTS
6.5 SOFTWARE
6.5.1 BLOOD BANK AND TRANSFUSION MANAGEMENT SOFTWARE
6.5.1.1 This software segment to register the highest growth rate over the forecast period
6.5.2 OTHER SOFTWARE
7 PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT
7.1 INTRODUCTION
7.2 WHOLE BLOOD
7.2.1 GROWING DISEASE INCIDENCE AND RISING SURGICAL VOLUMES ARE DRIVING THE DEMAND FOR WHOLE BLOOD UNITS
7.3 BLOOD COMPONENTS
7.3.1 EXPANDING APPLICATIONS OF BLOOD PLASMA AND PLATELETS TO SUPPORT MARKET GROWTH
8 PATIENT BLOOD MANAGEMENT MARKET, BY END USER
8.1 INTRODUCTION
8.2 BLOOD BANKS
8.2.1 HIGH DEMAND FOR SAFE BLOOD IS DRIVING THE GROWTH OF THIS END-USER SEGMENT
8.3 HOSPITALS
8.3.1 LARGE VOLUME OF SURGICAL PROCEDURES PERFORMED IN HOSPITALS—MAJOR FACTOR DRIVING THE GROWTH OF THIS END-USER SEGMENT
9 PATIENT BLOOD MANAGEMENT MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 The US dominates the patient blood management market due to the presence of well-developed healthcare infrastructure & growing adoption of advanced technologies
9.2.2 CANADA
9.2.2.1 Increasing number of surgical procedures performed in the country to drive the market for patient blood management products
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Rising number of trauma cases and accidents to support market growth
9.3.2 UK
9.3.2.1 Rising number of road traffic accidents will support the growth of this market
9.3.3 FRANCE
9.3.3.1 Rising prevalence of blood disorders to support market growth in France
9.3.4 ITALY
9.3.4.1 Increasing awareness about safe blood transfusion will drive market growth
9.3.5 SPAIN
9.3.5.1 Government mandates to deliver safe blood for transfusion to support market growth
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.1.1 Well-developed healthcare system and favorable reimbursement policy in the country to support market growth
9.4.2 CHINA
9.4.2.1 Market in China is estimated to grow at a high rate during the forecast period
9.4.3 INDIA
9.4.3.1 Favorable government initiatives to support market growth
9.4.4 AUSTRALIA
9.4.4.1 Presence of a highly developed healthcare system to contribute to market growth
9.4.5 SOUTH KOREA
9.4.5.1 Implementation of favorable government initiatives to support market growth
9.4.6 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 BRAZIL
9.5.1.1 Growing medical tourism to support market growth in Brazil
9.5.2 MEXICO
9.5.2.1 Lack of awareness about blood donations to hamper market growth
9.5.3 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET RANKING ANALYSIS, 2018
10.3 COMPETITIVE SCENARIO
10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2019)
10.3.2 PRODUCT LAUNCHES (2017–2019)
10.3.3 EXPANSIONS (2017–2019)
10.3.4 ACQUISITIONS (2017–2019)
10.4 COMPETITIVE LEADERSHIP MAPPING (2019)
10.4.1 VENDOR INCLUSION CRITERIA
10.4.2 VISIONARY LEADERS
10.4.3 INNOVATORS
10.4.4 DYNAMIC DIFFERENTIATORS
10.4.5 EMERGING COMPANIES
11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 ABBOTT LABORATORIES
11.2 ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF ASAHI KASEI CORPORATION)
11.3 B. BRAUN MELSUNGEN AG
11.4 BIOM?RIEUX SA
11.5 BIO-RAD LABORATORIES, INC.
11.6 DANAHER CORPORATION
11.7 F. HOFFMANN-LA ROCHE LTD.
11.8 FRESENIUS SE & CO. KGAA
11.9 GRIFOLS, S.A.
11.10 HAEMONETICS CORPORATION
11.11 IMMUCOR, INC.
11.12 KANEKA CORPORATION
11.13 LIVANOVA PLC
11.14 MACOPHARMA
11.15 TERUMO CORPORATION
11.16 OTHER COMPANIES
11.16.1 MEDIWARE INFORMATION SYSTEMS
11.16.2 KAWASUMI LABORATORIES, INC.
11.16.3 HAIER BIOMEDICAL
11.16.4 DIATRON
11.16.5 BAG DIAGNOSTICS GMBH
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 LEUKEMIA INCIDENCE AND PREVALENCE, BY COUNTRY, 2018
TABLE 2 PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 3 PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 4 PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 5 INSTRUMENTS MARKET SPLIT, BY COMPONENT
TABLE 6 INSTRUMENTS MARKET SPLIT, BY END USER
TABLE 7 BLOOD PROCESSING DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 8 BLOOD PROCESSING DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 BLOOD PROCESSING DEVICES MARKET FOR BLOOD CELL PROCESSORS, BY REGION, 2017–2024 (USD MILLION)
TABLE 10 BLOOD PROCESSING DEVICES MARKET FOR CENTRIFUGES, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 BLOOD TRANSFUSION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 12 BLOOD TRANSFUSION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 13 MEDICARE UNADJUSTED APC PAYMENT RATES FOR TRANSFUSION PROCEDURES AND THERAPEUTIC APHERESIS, 2019
TABLE 14 BLOOD TRANSFUSION DEVICES MARKET FOR APHERESIS MACHINES, BY REGION, 2017–2024 (USD MILLION)
TABLE 15 BLOOD TRANSFUSION DEVICES MARKET FOR CELL SALVAGE SYSTEMS, BY REGION, 2017–2024 (USD MILLION)
TABLE 16 BLOOD CULTURE SCREENING DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 17 BLOOD CULTURE SCREENING DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 18 BLOOD CULTURE SCREENING DEVICES MARKET FOR AUTOMATED BLOOD CULTURE SYSTEMS, BY REGION, 2017–2024 (USD MILLION)
TABLE 19 BLOOD CULTURE SCREENING DEVICES MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY REGION, 2017–2024 (USD MILLION)
TABLE 20 DIAGNOSTIC & TESTING INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 21 DIAGNOSTIC & TESTING INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 22 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR PCR INSTRUMENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 23 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR HEMATOLOGY ANALYZERS, BY REGION, 2017–2024 (USD MILLION)
TABLE 24 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR NGS PLATFORMS, BY REGION, 2017–2024 (USD MILLION)
TABLE 25 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR BLOOD GROUPING ANALYZERS, BY REGION, 2017–2024 (USD MILLION)
TABLE 26 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 27 BLOOD STORAGE DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 28 BLOOD STORAGE DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 29 BLOOD STORAGE DEVICES MARKET FOR MEDICAL REFRIGERATORS, BY REGION, 2017–2024 (USD MILLION)
TABLE 30 BLOOD STORAGE DEVICES MARKET FOR MEDICAL FREEZERS, BY REGION, 2017–2024 (USD MILLION)
TABLE 31 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 32 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 33 ACCESSORIES MARKET SPLIT, BY COMPONENT
TABLE 34 ACCESSORIES MARKET SPLIT, BY END USER
TABLE 35 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET FOR SYRINGES & NEEDLES, BY REGION, 2017–2024 (USD MILLION)
TABLE 36 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET FOR VIALS & TUBES, BY REGION, 2017–2024 (USD MILLION)
TABLE 37 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET FOR BLOOD BAGS, BY REGION, 2017–2024 (USD MILLION)
TABLE 38 OTHER PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 39 PATIENT BLOOD MANAGEMENT REAGENTS AND KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 40 PATIENT BLOOD MANAGEMENT REAGENTS AND KITS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 41 REAGENTS AND KITS MARKET SPLIT, BY COMPONENT
TABLE 42 REAGENTS AND KITS MARKET SPLIT, BY END USER
TABLE 43 PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD CULTURE MEDIA, BY REGION, 2017–2024 (USD MILLION)
TABLE 44 PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD TYPING REAGENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 45 PATIENT BLOOD MANAGEMENT MARKET FOR SLIDE STAINING REAGENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 46 PATIENT BLOOD MANAGEMENT MARKET FOR ASSAY KITS, BY REGION, 2017–2024 (USD MILLION)
TABLE 47 PATIENT BLOOD MANAGEMENT MARKET FOR OTHER REAGENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 48 PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 49 PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 50 SOFTWARE MARKET SPLIT, BY COMPONENT
TABLE 51 SOFTWARE MARKET SPLIT, BY END USER
TABLE 52 BLOOD BANK AND TRANSFUSION MANAGEMENT SOFTWARE MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 53 OTHER PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 54 PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 55 PATIENT BLOOD MANAGEMENT MARKET FOR WHOLE BLOOD, BY REGION, 2017–2024 (USD MILLION)
TABLE 56 PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD COMPONENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 57 PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 58 PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD BANKS, BY REGION, 2017–2024 (USD MILLION)
TABLE 59 PATIENT BLOOD MANAGEMENT MARKET FOR HOSPITALS, BY REGION, 2017–2024 (USD MILLION)
TABLE 60 PATIENT BLOOD MANAGEMENT MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 61 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 62 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 63 NORTH AMERICA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 64 NORTH AMERICA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 65 NORTH AMERICA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 66 NORTH AMERICA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 67 US: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 68 US: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 69 US: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 70 US: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 71 US: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 72 CANADA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 73 CANADA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 74 CANADA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 75 CANADA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 76 CANADA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 77 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 78 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 79 EUROPE: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 80 EUROPE: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 81 EUROPE: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 82 EUROPE: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 83 GERMANY: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 84 GERMANY: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 85 GERMANY: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 86 GERMANY: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 87 GERMANY: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 88 UK: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 89 UK: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 90 UK: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 91 UK: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 92 UK: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 93 FRANCE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 94 FRANCE: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 95 FRANCE: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 96 FRANCE: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 97 FRANCE: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 98 ITALY: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 99 ITALY: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 100 ITALY: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 101 ITALY: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 102 ITALY: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 103 SPAIN: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 104 SPAIN: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 105 SPAIN: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 106 SPAIN: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 107 SPAIN: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 108 ROE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 109 ROE: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 110 ROE: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 111 ROE: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 112 ROE: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 113 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 114 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 115 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 116 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 117 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 118 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 119 JAPAN: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 120 JAPAN: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 121 JAPAN: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 122 JAPAN: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 123 JAPAN: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 124 CHINA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 125 CHINA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 126 CHINA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 127 CHINA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 128 CHINA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 129 INDIA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 130 INDIA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 131 INDIA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 132 INDIA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 133 INDIA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 134 AUSTRALIA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 135 AUSTRALIA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 136 AUSTRALIA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 137 AUSTRALIA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 138 AUSTRALIA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 139 SOUTH KOREA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 140 SOUTH KOREA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 141 SOUTH KOREA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 142 SOUTH KOREA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 143 SOUTH KOREA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 144 ROAPAC: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 145 ROAPAC: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 146 ROAPAC: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 147 ROAPAC: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 148 ROAPAC: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 149 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 150 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 151 LATIN AMERICA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 152 LATIN AMERICA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 153 LATIN AMERICA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 154 LATIN AMERICA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 155 BRAZIL: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 156 BRAZIL: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 157 BRAZIL: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 158 BRAZIL: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 159 BRAZIL: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 160 MEXICO: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 161 MEXICO: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 162 MEXICO: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 163 MEXICO: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 164 MEXICO: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 165 ROLA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 166 ROLA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 167 ROLA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 168 ROLA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 169 ROLA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 170 MEA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 171 MEA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 172 MEA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 173 MEA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 174 MEA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 1 LEUKEMIA INCIDENCE AND PREVALENCE, BY COUNTRY, 2018
TABLE 2 PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 3 PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 4 PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 5 INSTRUMENTS MARKET SPLIT, BY COMPONENT
TABLE 6 INSTRUMENTS MARKET SPLIT, BY END USER
TABLE 7 BLOOD PROCESSING DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 8 BLOOD PROCESSING DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 BLOOD PROCESSING DEVICES MARKET FOR BLOOD CELL PROCESSORS, BY REGION, 2017–2024 (USD MILLION)
TABLE 10 BLOOD PROCESSING DEVICES MARKET FOR CENTRIFUGES, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 BLOOD TRANSFUSION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 12 BLOOD TRANSFUSION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 13 MEDICARE UNADJUSTED APC PAYMENT RATES FOR TRANSFUSION PROCEDURES AND THERAPEUTIC APHERESIS, 2019
TABLE 14 BLOOD TRANSFUSION DEVICES MARKET FOR APHERESIS MACHINES, BY REGION, 2017–2024 (USD MILLION)
TABLE 15 BLOOD TRANSFUSION DEVICES MARKET FOR CELL SALVAGE SYSTEMS, BY REGION, 2017–2024 (USD MILLION)
TABLE 16 BLOOD CULTURE SCREENING DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 17 BLOOD CULTURE SCREENING DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 18 BLOOD CULTURE SCREENING DEVICES MARKET FOR AUTOMATED BLOOD CULTURE SYSTEMS, BY REGION, 2017–2024 (USD MILLION)
TABLE 19 BLOOD CULTURE SCREENING DEVICES MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY REGION, 2017–2024 (USD MILLION)
TABLE 20 DIAGNOSTIC & TESTING INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 21 DIAGNOSTIC & TESTING INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 22 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR PCR INSTRUMENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 23 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR HEMATOLOGY ANALYZERS, BY REGION, 2017–2024 (USD MILLION)
TABLE 24 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR NGS PLATFORMS, BY REGION, 2017–2024 (USD MILLION)
TABLE 25 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR BLOOD GROUPING ANALYZERS, BY REGION, 2017–2024 (USD MILLION)
TABLE 26 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 27 BLOOD STORAGE DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 28 BLOOD STORAGE DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 29 BLOOD STORAGE DEVICES MARKET FOR MEDICAL REFRIGERATORS, BY REGION, 2017–2024 (USD MILLION)
TABLE 30 BLOOD STORAGE DEVICES MARKET FOR MEDICAL FREEZERS, BY REGION, 2017–2024 (USD MILLION)
TABLE 31 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 32 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 33 ACCESSORIES MARKET SPLIT, BY COMPONENT
TABLE 34 ACCESSORIES MARKET SPLIT, BY END USER
TABLE 35 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET FOR SYRINGES & NEEDLES, BY REGION, 2017–2024 (USD MILLION)
TABLE 36 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET FOR VIALS & TUBES, BY REGION, 2017–2024 (USD MILLION)
TABLE 37 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET FOR BLOOD BAGS, BY REGION, 2017–2024 (USD MILLION)
TABLE 38 OTHER PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 39 PATIENT BLOOD MANAGEMENT REAGENTS AND KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 40 PATIENT BLOOD MANAGEMENT REAGENTS AND KITS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 41 REAGENTS AND KITS MARKET SPLIT, BY COMPONENT
TABLE 42 REAGENTS AND KITS MARKET SPLIT, BY END USER
TABLE 43 PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD CULTURE MEDIA, BY REGION, 2017–2024 (USD MILLION)
TABLE 44 PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD TYPING REAGENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 45 PATIENT BLOOD MANAGEMENT MARKET FOR SLIDE STAINING REAGENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 46 PATIENT BLOOD MANAGEMENT MARKET FOR ASSAY KITS, BY REGION, 2017–2024 (USD MILLION)
TABLE 47 PATIENT BLOOD MANAGEMENT MARKET FOR OTHER REAGENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 48 PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 49 PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 50 SOFTWARE MARKET SPLIT, BY COMPONENT
TABLE 51 SOFTWARE MARKET SPLIT, BY END USER
TABLE 52 BLOOD BANK AND TRANSFUSION MANAGEMENT SOFTWARE MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 53 OTHER PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 54 PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 55 PATIENT BLOOD MANAGEMENT MARKET FOR WHOLE BLOOD, BY REGION, 2017–2024 (USD MILLION)
TABLE 56 PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD COMPONENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 57 PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 58 PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD BANKS, BY REGION, 2017–2024 (USD MILLION)
TABLE 59 PATIENT BLOOD MANAGEMENT MARKET FOR HOSPITALS, BY REGION, 2017–2024 (USD MILLION)
TABLE 60 PATIENT BLOOD MANAGEMENT MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 61 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 62 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 63 NORTH AMERICA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 64 NORTH AMERICA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 65 NORTH AMERICA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 66 NORTH AMERICA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 67 US: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 68 US: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 69 US: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 70 US: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 71 US: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 72 CANADA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 73 CANADA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 74 CANADA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 75 CANADA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 76 CANADA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 77 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 78 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 79 EUROPE: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 80 EUROPE: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 81 EUROPE: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 82 EUROPE: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 83 GERMANY: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 84 GERMANY: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 85 GERMANY: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 86 GERMANY: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 87 GERMANY: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 88 UK: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 89 UK: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 90 UK: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 91 UK: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 92 UK: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 93 FRANCE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 94 FRANCE: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 95 FRANCE: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 96 FRANCE: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 97 FRANCE: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 98 ITALY: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 99 ITALY: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 100 ITALY: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 101 ITALY: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 102 ITALY: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 103 SPAIN: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 104 SPAIN: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 105 SPAIN: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 106 SPAIN: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 107 SPAIN: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 108 ROE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 109 ROE: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 110 ROE: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 111 ROE: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 112 ROE: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 113 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 114 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 115 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 116 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 117 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 118 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 119 JAPAN: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 120 JAPAN: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 121 JAPAN: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 122 JAPAN: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 123 JAPAN: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 124 CHINA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 125 CHINA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 126 CHINA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 127 CHINA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 128 CHINA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 129 INDIA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 130 INDIA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 131 INDIA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 132 INDIA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 133 INDIA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 134 AUSTRALIA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 135 AUSTRALIA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 136 AUSTRALIA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 137 AUSTRALIA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 138 AUSTRALIA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 139 SOUTH KOREA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 140 SOUTH KOREA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 141 SOUTH KOREA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 142 SOUTH KOREA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 143 SOUTH KOREA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 144 ROAPAC: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 145 ROAPAC: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 146 ROAPAC: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 147 ROAPAC: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 148 ROAPAC: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 149 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 150 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 151 LATIN AMERICA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 152 LATIN AMERICA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 153 LATIN AMERICA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 154 LATIN AMERICA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 155 BRAZIL: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 156 BRAZIL: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 157 BRAZIL: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 158 BRAZIL: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 159 BRAZIL: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 160 MEXICO: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 161 MEXICO: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 162 MEXICO: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 163 MEXICO: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 164 MEXICO: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 165 ROLA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 166 ROLA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 167 ROLA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 168 ROLA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 169 ROLA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 170 MEA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 171 MEA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 172 MEA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 173 MEA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 174 MEA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION)
LIST OF FIGURES
FIGURE 1 PATIENT BLOOD MANAGEMENT MARKET: RESEARCH METHODOLOGY STEPS
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 PATIENT BLOOD MANAGEMENT MARKET: PRODUCT-BASED ESTIMATION
FIGURE 5 PATIENT BLOOD MANAGEMENT MARKET: END USER-BASED ESTIMATION
FIGURE 6 PATIENT BLOOD MANAGEMENT MARKET: DATA TRIANGULATION
FIGURE 7 PATIENT BLOOD MANAGEMENT MARKET SHARE, BY PRODUCT, 2019 VS. 2024
FIGURE 8 PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019 VS. 2024 (USD MILLION)
FIGURE 9 PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 10 PATIENT BLOOD MANAGEMENT MARKET, BY REGION
FIGURE 11 INCREASING DEMAND FOR DONATED BLOOD TO DRIVE MARKET GROWTH
FIGURE 12 INSTRUMENTS SEGMENT TO DOMINATE THE PATIENT BLOOD MANAGEMENT PRODUCTS MARKET DURING THE FORECAST PERIOD
FIGURE 13 BLOOD BANKS ARE THE LARGEST END USERS OF
PATIENT BLOOD MANAGEMENT PRODUCTS
FIGURE 14 APAC MARKET TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD (2019–2024)
FIGURE 15 PATIENT BLOOD MANAGEMENT MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 16 RATE OF ROAD TRAFFIC DEATHS PER 100,000 POPULATION, 2013 VS. 2016
FIGURE 17 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET SNAPSHOT
FIGURE 18 CANADA: NUMBER OF SURGICAL PROCEDURES, 2014–2017
FIGURE 19 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT MARKET SNAPSHOT
FIGURE 20 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2019
FIGURE 21 PATIENT BLOOD MANAGEMENT MARKET RANKING ANALYSIS, BY KEY PLAYER, 2018
FIGURE 22 PATIENT BLOOD MANAGEMENT SOFTWARE MARKET RANKING ANALYSIS, BY KEY PLAYER, 2018
FIGURE 23 GLOBAL PATIENT BLOOD MANAGEMENT MARKET: COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 24 ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 25 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
FIGURE 26 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
FIGURE 27 BIOM?RIEUX SA: COMPANY SNAPSHOT
FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 29 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 30 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 31 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT
FIGURE 32 GRIFOLS, S.A.: COMPANY SNAPSHOT
FIGURE 33 HAEMONETICS CORPORATION: COMPANY SNAPSHOT
FIGURE 34 KANEKA CORPORATION: COMPANY SNAPSHOT
FIGURE 35 LIVANOVA PLC: COMPANY SNAPSHOT
FIGURE 36 TERUMO CORPORATION: COMPANY SNAPSHOT
FIGURE 1 PATIENT BLOOD MANAGEMENT MARKET: RESEARCH METHODOLOGY STEPS
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 PATIENT BLOOD MANAGEMENT MARKET: PRODUCT-BASED ESTIMATION
FIGURE 5 PATIENT BLOOD MANAGEMENT MARKET: END USER-BASED ESTIMATION
FIGURE 6 PATIENT BLOOD MANAGEMENT MARKET: DATA TRIANGULATION
FIGURE 7 PATIENT BLOOD MANAGEMENT MARKET SHARE, BY PRODUCT, 2019 VS. 2024
FIGURE 8 PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019 VS. 2024 (USD MILLION)
FIGURE 9 PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 10 PATIENT BLOOD MANAGEMENT MARKET, BY REGION
FIGURE 11 INCREASING DEMAND FOR DONATED BLOOD TO DRIVE MARKET GROWTH
FIGURE 12 INSTRUMENTS SEGMENT TO DOMINATE THE PATIENT BLOOD MANAGEMENT PRODUCTS MARKET DURING THE FORECAST PERIOD
FIGURE 13 BLOOD BANKS ARE THE LARGEST END USERS OF
PATIENT BLOOD MANAGEMENT PRODUCTS
FIGURE 14 APAC MARKET TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD (2019–2024)
FIGURE 15 PATIENT BLOOD MANAGEMENT MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 16 RATE OF ROAD TRAFFIC DEATHS PER 100,000 POPULATION, 2013 VS. 2016
FIGURE 17 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET SNAPSHOT
FIGURE 18 CANADA: NUMBER OF SURGICAL PROCEDURES, 2014–2017
FIGURE 19 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT MARKET SNAPSHOT
FIGURE 20 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2019
FIGURE 21 PATIENT BLOOD MANAGEMENT MARKET RANKING ANALYSIS, BY KEY PLAYER, 2018
FIGURE 22 PATIENT BLOOD MANAGEMENT SOFTWARE MARKET RANKING ANALYSIS, BY KEY PLAYER, 2018
FIGURE 23 GLOBAL PATIENT BLOOD MANAGEMENT MARKET: COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 24 ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 25 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
FIGURE 26 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
FIGURE 27 BIOM?RIEUX SA: COMPANY SNAPSHOT
FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 29 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 30 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 31 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT
FIGURE 32 GRIFOLS, S.A.: COMPANY SNAPSHOT
FIGURE 33 HAEMONETICS CORPORATION: COMPANY SNAPSHOT
FIGURE 34 KANEKA CORPORATION: COMPANY SNAPSHOT
FIGURE 35 LIVANOVA PLC: COMPANY SNAPSHOT
FIGURE 36 TERUMO CORPORATION: COMPANY SNAPSHOT
